These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25206480)

  • 1. The calmodulin-dependent protein kinase II inhibitor KN-93 protects rat cerebral cortical neurons from N-methyl-D-aspartic acid-induced injury.
    Liu X; Ma C; Xing R; Zhang W; Tian B; Li X; Li Q; Zhang Y
    Neural Regen Res; 2013 Jan; 8(2):111-20. PubMed ID: 25206480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
    Tokumitsu H; Chijiwa T; Hagiwara M; Mizutani A; Terasawa M; Hidaka H
    J Biol Chem; 1990 Mar; 265(8):4315-20. PubMed ID: 2155222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KN-62 provides neuroprotection against glutamate-induced excitotoxicity in neurons.
    Gao C; Zhang GY
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):991-4. PubMed ID: 11270980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
    Williams CL; Phelps SH; Porter RA
    Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of calcium/calmodulin-dependent protein kinase type II subunit δ after rat traumatic brain injury.
    Zhang M; Shan H; Gu Z; Wang D; Wang T; Wang Z; Tao L
    J Mol Neurosci; 2012 Mar; 46(3):631-43. PubMed ID: 22048920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death.
    Hajimohammadreza I; Probert AW; Coughenour LL; Borosky SA; Marcoux FW; Boxer PA; Wang KK
    J Neurosci; 1995 May; 15(5 Pt 2):4093-101. PubMed ID: 7538570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of late sodium current by Ca
    Fu C; Hao J; Zeng M; Song Y; Jiang W; Zhang P; Luo A; Cao Z; Belardinelli L; Ma J
    Exp Physiol; 2017 Jul; 102(7):818-834. PubMed ID: 28436159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of insulin secretion from permeabilized pancreatic beta-cells on the activation of Ca(2+)/calmodulin-dependent protein kinase II. A re-evaluation of inhibitor studies.
    Bhatt HS; Conner BP; Prasanna G; Yorio T; Easom RA
    Biochem Pharmacol; 2000 Dec; 60(11):1655-63. PubMed ID: 11077048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.
    Brozinick JT; Reynolds TH; Dean D; Cartee G; Cushman SW
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):533-40. PubMed ID: 10215590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat.
    Ishikawa N; Hashiba Y; Hidaka H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):598-602. PubMed ID: 2384887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of voltage-gated Ca2+ channels and insulin secretion in HIT cells by the Ca2+/calmodulin-dependent protein kinase II inhibitor KN-62: comparison with antagonists of calmodulin and L-type Ca2+ channels.
    Li G; Hidaka H; Wollheim CB
    Mol Pharmacol; 1992 Sep; 42(3):489-8. PubMed ID: 1328847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KN-62, a specific Ca++/calmodulin-dependent protein kinase inhibitor, reversibly depresses the rate of beating of cultured fetal mouse cardiac myocytes.
    Okazaki K; Ishikawa T; Inui M; Tada M; Goshima K; Okamoto T; Hidaka H
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1319-24. PubMed ID: 7932185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca(2+)-dependent enhancement of [3H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases.
    Uchida J; Kiuchi Y; Ohno M; Yura A; Oguchi K
    Brain Res; 1998 Nov; 809(2):155-64. PubMed ID: 9853106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium/calmodulin-dependent protein kinase II involvement in release of gonadotropin-releasing hormone.
    Waters WW; Chen PL; McArthur NH; Moreno PA; Harms PG
    Neuroendocrinology; 1998 Mar; 67(3):145-52. PubMed ID: 9630431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
    Kawamura K; Grabowski D; Krivacic K; Hidaka H; Ganapathi R
    Biochem Pharmacol; 1996 Dec; 52(12):1903-9. PubMed ID: 8951349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides.
    Ronkainen JJ; Vuolteenaho O; Tavi P
    Endocrinology; 2007 Jun; 148(6):2815-20. PubMed ID: 17332063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of voltage-gated Ca2+ channel activity in small cell lung carcinoma by the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperaz ine) .
    Williams CL; Porter RA; Phelps SH
    Biochem Pharmacol; 1995 Dec; 50(12):1979-85. PubMed ID: 8849323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of the seizure-induced expression of BDNF mRNA in adult rat brain by an inhibitor of calcium/calmodulin-dependent protein kinases.
    Murray KD; Hayes VY; Gall CM; Isackson PJ
    Eur J Neurosci; 1998 Jan; 10(1):377-87. PubMed ID: 9753146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes.
    Grabowski DR; Dubyak GR; Rybicki L; Hidaka H; Ganapathi R
    Biochem Pharmacol; 1998 Aug; 56(3):345-9. PubMed ID: 9744572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin and calmodulin-dependent kinase II mediate neuronal cell death induced by depolarization.
    Takano H; Fukushi H; Morishima Y; Shirasaki Y
    Brain Res; 2003 Feb; 962(1-2):41-7. PubMed ID: 12543454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.